Pharmacie la Licorne
ActiveSummary
Pharmacie la Licorne has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €147k and a net result of €-924. Equity is growing by ~5.9% per year across the filed fiscal years. Its solvency ranks better than 68% of 18280 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.4% (low).
Checked score
Score 2025
65
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability38▲+15
Solvency80▼-6
Growth52=
Track record100
Bankruptcy probability, 12 months
1.4%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €9k at 30 days acceptable
Liquidity ample (current ratio 2.12 against 2.25 in 2024; short-term debt: 43.2% and cash: 46.9% of total assets), and 44.7% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025Net result per financial year
1819202122232425
2018 to 2025 · latest year €-924
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
31 d late
2024
4 d late
2023
29 d late
2022
42 d early
2021
27 d early
2020
27 d late
2019
18 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€147k▼ 0.6%
2024 · €148k
2018: €98k
2019: €115k
2020: €127k
2021: €139k
2022: €169k
2023: €156k
2024: €148k
2018 → 2025
Total assets
€266k▲ 10.3%
2024 · €241k
2018: €213k
2019: €309k
2020: €300k
2021: €304k
2022: €330k
2023: €283k
2024: €241k
2018 → 2025
Net result
€-924▲ 88.5%
2024 · €-8k
2018: €9k
2019: €19k
2020: €13k
2021: €12k
2022: €30k
2023: €-13k
2024: €-8k
2018 → 2025
Working capital
€129k▲ 9.9%
2024 · €117k
2018: €36k
2019: €45k
2020: €67k
2021: €86k
2022: €121k
2023: €116k
2024: €117k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€139k-€169k▲ 21.5%€156k▼ 7.7%€148k▼ 5.1%€147k▼ 0.6%
Operating result€21k-€47k▲ 125%€-9k€-5k▲ 39.9%€-395▲ 92.7%
Net result€12k-€30k▲ 150%€-13k€-8k▲ 38.7%€-924▲ 88.5%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €395 in 2025 against €5k in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €266k
Fixed assets
€22k ▼ 27.5%
Current assets
€244k ▲ 15.8%
Equity and liabilities €266k
Equity
€147k ▼ 0.6%
Debt
€119k ▲ 27.5%
Debt's share of the balance-sheet total rises from 38.7% to 44.7%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€8k▲
2024 · €4k
Cash flow
€8k▲
2024 · €2k
Current ratio
2.12▼
2024 · 2.25
Quick ratio
1.72▼
2024 · 1.74
Debt to equity
0.81▲
2024 · 0.63
ROE
-0.6%▲
2024 · -5.4%
ROA
-0.3%▲
2024 · -3.3%
Interest coverage
2.41▲
2024 · 1.02
Debt ≤ 1 year
€115k▲
2024 · €93k
Income taxes
€154▲
2024 · €144
Staff costs
€85k▲
2024 · €84k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 46 lines
Balance sheet
Code20242025
Assets
Total assets20/58€241k€266k▲
Fixed assets21/28€31k€22k▼
Intangible fixed assets21€29k€22k▼
Tangible fixed assets22/27€2k€416▼
Plant, machinery and equipment23€1k€416▼
Furniture and vehicles24€439-
Financial fixed assets28€50€50=
Current assets29/58€210k€244k▲
Stocks and contracts in progress3€48k€45k▼
Stocks30/36€48k€45k▼
Amounts receivable within one year40/41€18k€25k▲
Trade receivables40€13k€19k▲
Other amounts receivable41€5k€6k▲
Current investments50/53€125k€45k▼
Cash at bank and in hand54/58€19k€125k▲
Deferred charges and accrued income490/1€1k€3k▲
Equity and liabilities
Total equity and liabilities10/49€241k€266k▲
Equity10/15€148k€147k▼
Contributions10/11€70k€70k=
Reserves13€7k€7k=
Distributable reserves133€7k€7k=
Profit (loss) carried forward14€71k€70k▼
Amounts payable17/49€93k€119k▲
Amounts payable within one year42/48€93k€115k▲
Trade debts44€28k€50k▲
Suppliers440/4€28k€50k▲
Taxes, remuneration and social security45€19k€18k▼
Taxes450/3€4k€5k▲
Remuneration and social security454/9€14k€13k▼
Other amounts payable47/48€47k€47k▲
Accrued charges and deferred income492/3-€4k
Income statement
Code20242025
Remuneration, social security and pensions62€84k€85k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€10k€8k▼
Other operating charges640/8€0€1▲
Gross operating margin9900€89k€93k▲
Operating profit (loss)9901€-5k€-395▲
Financial income75/76B€2k€3k▲
Recurring financial income75€2k€3k▲
Financial charges65/66B€4k€3k▼
Recurring financial charges65€4k€3k▼
Profit (loss) for the period before taxes9903€-8k€-770▲
Income taxes67/77€144€154▲
Profit (loss) for the period9904€-8k€-924▲
Profit (loss) for the period to be appropriated9905€-8k€-924▲
Appropriation of the result
Profit (loss) to be appropriated9906€71k€70k▼
Profit (loss) brought forward from the previous period14P€79k€71k▼
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 31 days late
2025
04-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 4 days late
2024
29-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 29 days late
2023
31-12
Financial
Weakest financial yearnet €-13k ▼144%
Net result drops to €-13k, the lowest in the series; recovery starts the following year.
19-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Highest result since 2018net €30k ▲150%
Operating result €47k, net result €30k, both a record.
31-12
Financial
Equity above €150kEq €169k ▲21.5%
5 profitable years in a row build equity to €169k.
04-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
27-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 27 days late
2020
18-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 18 days late
2019
31-12
Financial
Equity above €100kEq €115k ▲17.4%
2 profitable years in a row build equity to €115k.
19-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
27-06
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
25-07
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Brussel · 1 establishment unit since 2013
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Kortenberglaan 661000 BrusselGround area
484 m²
Building footprint
482 m²
Volume, LiDAR
7,510 m³
Parcel 21806F0351/00T000, Brussels · tallest building 29.0 m, ±7 floors. Linked by address, not a title deed.
1 establishment unit
Pharmacie la Licorne
since 20132.215.648.462
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21806F0351/00T000 | Brussels | 484 m² | 1 · 482 m² | 29.0 m · 7 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteBrussel2.215.648.462
Similar companies · same sector, comparable size
PHARMACIE PLACE BOCKSTAEL
BE 0460.684.177
Brussel · Eq €147,109
CORIPHAR
BE 0437.150.690
Tienen · Eq €146,896
ASTELLA
BE 0779.903.952
Bilzen-Hoeselt · Eq €146,888
APOTHEEK PHLIPPO
BE 0443.030.276
Lommel · Eq €147,290
Apotheek Farmapunt Berchem
BE 0426.679.739
Antwerpen · Eq €146,730
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,566 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded26-12-2012
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 13 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.